{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:20:24Z","timestamp":1793866824031,"version":"4.6.1"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","award":["contract A-17778"],"award-info":[{"award-number":["contract A-17778"]}],"id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CampagneTeam Huntington"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Huntington\u2019s disease (HD) is a neurodegenerative disorder in which mutated fragments of the huntingtin protein (Htt) undergo misfolding and aggregation. Since aggregated proteins can cause cellular stress and cytotoxicity, there is an interest in the development of small molecule aggregation inhibitors as potential modulators of HD pathogenesis. Here, we study how a polyphenol modulates the aggregation mechanism of huntingtin exon 1 (HttEx1) even at sub-stoichiometric ratios. Sub-stoichiometric amounts of curcumin impacted the primary and\/or secondary nucleation events, extending the pre-aggregation lag phase. Remarkably, the disrupted aggregation process changed both the aggregate structure and its cell metabolic properties. When administered to neuronal cells, the \u2018break-through\u2019 protein aggregates induced significantly reduced cellular stress compared to aggregates formed in absence of inhibitors. Structural analysis by electron microscopy, small angle X-ray scattering (SAXS), and solid-state NMR spectroscopy identified changes in the fibril structures, probing the flanking domains in the fuzzy coat and the fibril core. We propose that changes in the latter relate to the presence or absence of polyglutamine (polyQ) \u03b2-hairpin structures. Our findings highlight multifaceted consequences of small molecule inhibitors that modulate the protein misfolding landscape, with potential implications for treatment strategies in HD and other amyloid disorders.<\/jats:p>","DOI":"10.1038\/s41467-025-58691-9","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T13:51:21Z","timestamp":1744725081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Inhibitor-based modulation of huntingtin aggregation mechanisms mitigates fibril-induced cellular stress"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1907-1100","authenticated-orcid":false,"given":"Greeshma","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3687-6210","authenticated-orcid":false,"given":"Marina","family":"Trombetta-Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Matlahov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hennrique Taborda","family":"Ribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Parlato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4903-3159","authenticated-orcid":false,"given":"Giuseppe","family":"Portale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5400-5614","authenticated-orcid":false,"given":"Amalia M.","family":"Dolga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5390-3321","authenticated-orcid":false,"given":"Patrick C. A.","family":"van der Wel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"58691_CR1","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/nm1066","volume":"10","author":"CA Ross","year":"2004","unstructured":"Ross, C. A. & Poirier, M. A. Protein aggregation and neurodegenerative disease. Nat. Med. 10, S10\u2013S17 (2004).","journal-title":"Nat. Med."},{"key":"58691_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti, F. & Dobson, C. M. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu Rev. Biochem 86, 27\u201368 (2017).","journal-title":"Annu Rev. Biochem"},{"key":"58691_CR3","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/iub.111","volume":"60","author":"DM Hatters","year":"2008","unstructured":"Hatters, D. M. Protein misfolding inside cells: The case of huntingtin and huntington\u2019s disease. IUBMB Life 60, 724\u2013728 (2008).","journal-title":"IUBMB Life"},{"key":"58691_CR4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","volume":"16","author":"SJ Tabrizi","year":"2020","unstructured":"Tabrizi, S. J., Flower, M. D., Ross, C. A. & Wild, E. J. Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat. Rev. Neurol. 16, 529\u2013546 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"58691_CR5","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates, G. P. et al. Huntington disease. Nat. Rev. Dis. Prim. 1, 15005 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"58691_CR6","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Sci. N. Y. NY 277, 1990\u20131993 (1997).","journal-title":"Sci. N. Y. NY"},{"key":"58691_CR7","doi-asserted-by":"publisher","first-page":"8608","DOI":"10.1021\/acs.jmedchem.0c00955","volume":"63","author":"L Liu","year":"2020","unstructured":"Liu, L. et al. Imaging mutant huntingtin aggregates: development of a potential PET ligand. J. Med. Chem. 63, 8608\u20138633 (2020).","journal-title":"J. Med. Chem."},{"key":"58691_CR8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.molcel.2018.07.032","volume":"71","author":"A Ast","year":"2018","unstructured":"Ast, A. et al. mHTT Seeding activity: A marker of disease progression and neurotoxicity in models of huntington\u2019s disease. Mol. Cell 71, 675\u2013688.e6 (2018).","journal-title":"Mol. Cell"},{"key":"58691_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77164-1","volume":"10","author":"CYD Lee","year":"2020","unstructured":"Lee, C. Y. D. et al. Disease-related huntingtin seeding activities in cerebrospinal fluids of huntington\u2019s disease patients. Sci. Rep. 10, 20295 (2020).","journal-title":"Sci. Rep."},{"key":"58691_CR10","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1093\/hmg\/11.23.2905","volume":"11","author":"W Yang","year":"2002","unstructured":"Yang, W., Dunlap, J. R., Andrews, R. B. & Wetzel, R. Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum. Mol. Genet 11, 2905\u20132917 (2002).","journal-title":"Hum. Mol. Genet"},{"key":"58691_CR11","doi-asserted-by":"publisher","first-page":"9679","DOI":"10.1073\/pnas.0812083106","volume":"106","author":"Y Nekooki-Machida","year":"2009","unstructured":"Nekooki-Machida, Y. et al. Distinct conformations of in vitro and in vivo amyloids of huntingtin-exon1 show different cytotoxicity. Proc. Natl Acad. Sci. USA 106, 9679\u20139684 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58691_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24411-2","volume":"12","author":"J Mario Isas","year":"2021","unstructured":"Mario Isas, J. et al. Huntingtin fibrils with different toxicity, structure, and seeding potential can be interconverted. Nat. Commun. 12, 4272 (2021).","journal-title":"Nat. Commun."},{"key":"58691_CR13","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M Arrasate","year":"2004","unstructured":"Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R. & Finkbeiner, S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431, 805\u2013810 (2004).","journal-title":"Nature"},{"key":"58691_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15462","volume":"8","author":"H-K Lin","year":"2017","unstructured":"Lin, H.-K. et al. Fibril polymorphism affects immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core. Nat. Commun. 8, 15462 (2017).","journal-title":"Nat. Commun."},{"key":"58691_CR15","doi-asserted-by":"publisher","first-page":"10723","DOI":"10.1021\/jacs.2c00509","volume":"144","author":"S Nazarov","year":"2022","unstructured":"Nazarov, S., Chiki, A., Boudeffa, D. & Lashuel, H. A. Structural basis of huntingtin fibril polymorphism revealed by cryogenic electron microscopy of exon 1 HTT Fibrils. J. Am. Chem. Soc. 144, 10723\u201310735 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"58691_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep00895","volume":"2","author":"SJ Sahl","year":"2012","unstructured":"Sahl, S. J., Weiss, L. E., Duim, W. C., Frydman, J. & Moerner, W. E. Cellular inclusion bodies of mutant huntingtin exon 1 obscure small fibrillar aggregate species. Sci. Rep. 2, 895 (2012).","journal-title":"Sci. Rep."},{"key":"58691_CR17","doi-asserted-by":"publisher","first-page":"6739","DOI":"10.1073\/pnas.110138997","volume":"97","author":"V Heiser","year":"2000","unstructured":"Heiser, V. et al. Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for huntington\u2019s disease therapy. Proc. Natl Acad. Sci. USA. 97, 6739\u20136744 (2000).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"58691_CR18","doi-asserted-by":"publisher","first-page":"621996","DOI":"10.3389\/fnins.2021.621996","volume":"15","author":"EN Minakawa","year":"2021","unstructured":"Minakawa, E. N. & Nagai, Y. Protein aggregation inhibitors as disease-modifying therapies for polyglutamine diseases. Front. Neurosci. 15, 621996 (2021).","journal-title":"Front. Neurosci."},{"key":"58691_CR19","doi-asserted-by":"publisher","first-page":"4722","DOI":"10.1016\/j.jmb.2020.06.021","volume":"432","author":"JC Boatz","year":"2020","unstructured":"Boatz, J. C. et al. Protofilament structure and supramolecular polymorphism of aggregated mutant huntingtin exon 1. J. Mol. Biol. 432, 4722\u20134744 (2020).","journal-title":"J. Mol. Biol."},{"key":"58691_CR20","doi-asserted-by":"publisher","first-page":"31739","DOI":"10.1074\/jbc.M112.353839","volume":"287","author":"CW Bugg","year":"2012","unstructured":"Bugg, C. W., Isas, J. M., Fischer, T., Patterson, P. H. & Langen, R. Structural features and domain organization of huntingtin fibrils. J. Biol. Chem. 287, 31739\u201331746 (2012).","journal-title":"J. Biol. Chem."},{"key":"58691_CR21","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1177\/1535370219856620","volume":"244","author":"I Matlahov","year":"2019","unstructured":"Matlahov, I. & van der Wel, P. C. Conformational studies of pathogenic expanded polyglutamine protein deposits from Huntington\u2019s disease. Exp. Biol. Med Maywood 244, 1584\u20131595 (2019).","journal-title":"Exp. Biol. Med Maywood"},{"key":"58691_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cell.2017.08.009","volume":"171","author":"FJB B\u00e4uerlein","year":"2017","unstructured":"B\u00e4uerlein, F. J. B. et al. In situ architecture and cellular interactions of polyq inclusions. Cell 171, 179\u2013187.e10 (2017).","journal-title":"Cell"},{"key":"58691_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55062-8","volume":"15","author":"M Bagherpoor Helabad","year":"2024","unstructured":"Bagherpoor Helabad, M. et al. Integrative determination of atomic structure of mutant huntingtin exon 1 fibrils implicated in Huntington disease. Nat. Commun. 15, 10793 (2024).","journal-title":"Nat. Commun."},{"key":"58691_CR24","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1073\/pnas.96.8.4604","volume":"96","author":"E Scherzinger","year":"1999","unstructured":"Scherzinger, E. et al. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington\u2019s disease pathology. Proc. Natl Acad. Sci. USA. 96, 4604\u20134609 (1999).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"58691_CR25","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/j.bpj.2020.10.010","volume":"119","author":"AS Falk","year":"2020","unstructured":"Falk, A. S. et al. Structural model of the proline-rich domain of huntingtin exon-1 fibrils. Biophys. J. 119, 2019\u20132028 (2020).","journal-title":"Biophys. J."},{"key":"58691_CR26","doi-asserted-by":"publisher","first-page":"6653","DOI":"10.1021\/bi501010q","volume":"53","author":"CL Hoop","year":"2014","unstructured":"Hoop, C. L. et al. Polyglutamine amyloid core boundaries and flanking domain dynamics in huntingtin fragment fibrils determined by solid-state nuclear magnetic resonance. Biochemistry 53, 6653\u20136666 (2014).","journal-title":"Biochemistry"},{"key":"58691_CR27","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1073\/pnas.1521933113","volume":"113","author":"CL Hoop","year":"2016","unstructured":"Hoop, C. L. et al. Huntingtin exon 1 fibrils feature an interdigitated \u03b2-hairpin\u2013based polyglutamine core. Proc. Natl Acad. Sci. USA 113, 1546\u20131551 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58691_CR28","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1021\/acs.biochem.5b00281","volume":"54","author":"JM Isas","year":"2015","unstructured":"Isas, J. M., Langen, R. & Siemer, A. B. Solid-state nuclear magnetic resonance on the static and dynamic domains of huntingtin exon-1 Fibrils. Biochemistry 54, 3942\u20133949 (2015).","journal-title":"Biochemistry"},{"key":"58691_CR29","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1021\/acs.biochem.7b00138","volume":"56","author":"JM Isas","year":"2017","unstructured":"Isas, J. M., Langen, A., Isas, M. C., Pandey, N. K. & Siemer, A. B. Formation and structure of wild type huntingtin exon-1 Fibrils. Biochemistry 56, 3579\u20133586 (2017).","journal-title":"Biochemistry"},{"key":"58691_CR30","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1042\/BST20230731","volume":"52","author":"PCA Van der Wel","year":"2024","unstructured":"Van der Wel, P. C. A. Solid-state nuclear magnetic resonance in the structural study of polyglutamine aggregation. Biochem. Soc. Trans. 52, 719\u2013731 (2024).","journal-title":"Biochem. Soc. Trans."},{"key":"58691_CR31","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1021\/ja110715f","volume":"133","author":"VN Sivanandam","year":"2011","unstructured":"Sivanandam, V. N. et al. The aggregation-enhancing huntingtin N-terminus is helical in amyloid fibrils. J. Am. Chem. Soc. 133, 4558\u20134566 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"58691_CR32","doi-asserted-by":"publisher","first-page":"102662","DOI":"10.1016\/j.jbc.2022.102662","volume":"298","author":"S Mafimoghaddam","year":"2022","unstructured":"Mafimoghaddam, S. et al. Suppression of amyloid-\u03b2 fibril growth by drug-engineered polymorph transformation. J. Biol. Chem. 298, 102662 (2022).","journal-title":"J. Biol. Chem."},{"key":"58691_CR33","first-page":"459","volume":"10","author":"YJ Yu","year":"2013","unstructured":"Yu, Y. J. & Watts, R. J. Developing therapeutic antibodies for neurodegenerative disease. Neurother. J. Am. Soc. Exp. Neurother. 10, 459\u2013472 (2013).","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"58691_CR34","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1073\/pnas.0408936102","volume":"102","author":"X Zhang","year":"2005","unstructured":"Zhang, X. et al. A potent small molecule inhibits polyglutamine aggregation in Huntington\u2019s disease neurons and suppresses neurodegeneration in vivo. Proc. Natl Acad. Sci. USA. 102, 892\u2013897 (2005).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"58691_CR35","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/d41573-021-00088-6","volume":"20","author":"K Kingwell","year":"2021","unstructured":"Kingwell, K. Double setback for ASO trials in Huntington disease. Nat. Rev. Drug Discov. 20, 412\u2013413 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"58691_CR36","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nsmb.1437","volume":"15","author":"DE Ehrnhoefer","year":"2008","unstructured":"Ehrnhoefer, D. E. et al. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol. 15, 558\u2013566 (2008).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"58691_CR37","doi-asserted-by":"publisher","first-page":"10481","DOI":"10.1073\/pnas.1804198115","volume":"115","author":"J Pujols","year":"2018","unstructured":"Pujols, J. et al. Small molecule inhibits \u03b1-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons. Proc. Natl Acad. Sci. USA. 115, 10481\u201310486 (2018).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"58691_CR38","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.jmb.2018.03.017","volume":"430","author":"AS Wagner","year":"2018","unstructured":"Wagner, A. S. et al. Self-assembly of mutant huntingtin exon-1 fragments into large complex fibrillar structures involves nucleated branching. J. Mol. Biol. 430, 1725\u20131744 (2018).","journal-title":"J. Mol. Biol."},{"key":"58691_CR39","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1021\/acschemneuro.5b00214","volume":"7","author":"A Thapa","year":"2016","unstructured":"Thapa, A., Jett, S. D. & Chi, E. Y. Curcumin attenuates amyloid-\u03b2 aggregate toxicity and modulates amyloid-\u03b2 aggregation pathway. ACS Chem. Neurosci. 7, 56\u201368 (2016).","journal-title":"ACS Chem. Neurosci."},{"key":"58691_CR40","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.arr.2012.01.006","volume":"11","author":"A Ebrahimi","year":"2012","unstructured":"Ebrahimi, A. & Schluesener, H. Natural polyphenols against neurodegenerative disorders: Potentials and pitfalls. Ageing Res. Rev. 11, 329\u2013345 (2012).","journal-title":"Ageing Res. Rev."},{"key":"58691_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejphar.2006.06.025","volume":"545","author":"C Ramassamy","year":"2006","unstructured":"Ramassamy, C. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur. J. Pharmacol. 545, 51\u201364 (2006).","journal-title":"Eur. J. Pharmacol."},{"key":"58691_CR42","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1021\/acs.jmedchem.6b00975","volume":"60","author":"KM Nelson","year":"2017","unstructured":"Nelson, K. M. et al. The essential medicinal chemistry of curcumin. J. Med. Chem. 60, 1620\u20131637 (2017).","journal-title":"J. Med. Chem."},{"key":"58691_CR43","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand, P., Kunnumakkara, A. B., Newman, R. A. & Aggarwal, B. B. Bioavailability of curcumin: Problems and promises. Mol. Pharm. 4, 807\u2013818 (2007).","journal-title":"Mol. Pharm."},{"key":"58691_CR44","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00401-007-0332-4","volume":"115","author":"N Pandey","year":"2008","unstructured":"Pandey, N., Strider, J., Nolan, W. C., Yan, S. X. & Galvin, J. E. Curcumin inhibits aggregation of alpha-synuclein. Acta Neuropathol. (Berl.) 115, 479\u2013489 (2008).","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"58691_CR45","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/jnr.20025","volume":"75","author":"K Ono","year":"2004","unstructured":"Ono, K., Hasegawa, K., Naiki, H. & Yamada, M. Curcumin has potent anti-amyloidogenic effects for alzheimer\u2019s \u03b2-amyloid fibrils in vitro. J. Neurosci. Res. 75, 742\u2013750 (2004).","journal-title":"J. Neurosci. Res."},{"key":"58691_CR46","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.1074\/jbc.M404751200","volume":"280","author":"F Yang","year":"2005","unstructured":"Yang, F. et al. Curcumin inhibits formation of amyloid \u03b2 oligomers and fibrils, binds plaques, and reduces amyloid in vivo*. J. Biol. Chem. 280, 5892\u20135901 (2005).","journal-title":"J. Biol. Chem."},{"key":"58691_CR47","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1021\/cn3001203","volume":"4","author":"PK Singh","year":"2013","unstructured":"Singh, P. K. et al. Curcumin modulates \u03b1-synuclein aggregation and toxicity. ACS Chem. Neurosci. 4, 393\u2013407 (2013).","journal-title":"ACS Chem. Neurosci."},{"key":"58691_CR48","doi-asserted-by":"publisher","first-page":"E200","DOI":"10.1073\/pnas.1615613114","volume":"114","author":"J Habchi","year":"2017","unstructured":"Habchi, J. et al. Systematic development of small molecules to inhibit specific microscopic steps of A\u03b242 aggregation in Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 114, E200\u2013E208 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58691_CR49","doi-asserted-by":"publisher","first-page":"24251","DOI":"10.1073\/pnas.2006684117","volume":"117","author":"TCT Michaels","year":"2020","unstructured":"Michaels, T. C. T. et al. Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors. Proc. Natl Acad. Sci. USA 117, 24251\u201324257 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58691_CR50","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd4593","volume":"14","author":"YS Eisele","year":"2015","unstructured":"Eisele, Y. S. et al. Targeting protein aggregation for the treatment of degenerative diseases. Nat. Rev. Drug Discov. 14, 759\u2013780 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"58691_CR51","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41580-018-0060-8","volume":"19","author":"MG Iadanza","year":"2018","unstructured":"Iadanza, M. G., Jackson, M. P., Hewitt, E. W., Ranson, N. A. & Radford, S. E. A new era for understanding amyloid structures and disease. Nat. Rev. Mol. Cell Biol. 19, 755\u2013773 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"58691_CR52","doi-asserted-by":"publisher","first-page":"7606","DOI":"10.1039\/C4CP05563B","volume":"17","author":"P Arosio","year":"2015","unstructured":"Arosio, P., Knowles, T. P. J. & Linse, S. On the lag phase in amyloid fibril formation. Phys. Chem. Chem. Phys. 17, 7606\u20137618 (2015).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"58691_CR53","doi-asserted-by":"publisher","first-page":"5960","DOI":"10.1111\/j.1742-4658.2009.07307.x","volume":"276","author":"SA Hudson","year":"2009","unstructured":"Hudson, S. A., Ecroyd, H., Kee, T. W. & Carver, J. A. The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds. FEBS J. 276, 5960\u20135972 (2009).","journal-title":"FEBS J."},{"key":"58691_CR54","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.bpj.2014.06.002","volume":"107","author":"T Perevozchikova","year":"2014","unstructured":"Perevozchikova, T., Stanley, C. B., McWilliams-Koeppen, H. P., Rowe, E. L. & Berthelier, V. Investigating the structural impact of the glutamine repeat in huntingtin assembly. Biophys. J. 107, 411\u2013421 (2014).","journal-title":"Biophys. J."},{"key":"58691_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/srep19180","volume":"6","author":"E Monsellier","year":"2016","unstructured":"Monsellier, E., Bousset, L. & Melki, R. \u03b1-Synuclein and huntingtin exon 1 amyloid fibrils bind laterally to the cellular membrane. Sci. Rep. 6, 19180 (2016).","journal-title":"Sci. Rep."},{"key":"58691_CR56","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ymeth.2018.04.015","volume":"148","author":"I Matlahov","year":"2018","unstructured":"Matlahov, I. & van der Wel, P. C. A. Hidden motions and motion-induced invisibility: Dynamics-based spectral editing in solid-state NMR. Methods San. Diego Calif. 148, 123\u2013135 (2018).","journal-title":"Methods San. Diego Calif."},{"key":"58691_CR57","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jmb.2011.06.045","volume":"412","author":"R Schneider","year":"2011","unstructured":"Schneider, R. et al. Structural characterization of polyglutamine fibrils by solid-state NMR spectroscopy. J. Mol. Biol. 412, 121\u2013136 (2011).","journal-title":"J. Mol. Biol."},{"key":"58691_CR58","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1146\/annurev-physchem-050317-021322","volume":"69","author":"TCT Michaels","year":"2018","unstructured":"Michaels, T. C. T. et al. Chemical kinetics for bridging molecular mechanisms and macroscopic measurements of amyloid fibril formation. Annu. Rev. Phys. Chem. 69, 273\u2013298 (2018).","journal-title":"Annu. Rev. Phys. Chem."},{"key":"58691_CR59","doi-asserted-by":"publisher","first-page":"e2021888118","DOI":"10.1073\/pnas.2021888118","volume":"118","author":"T Sinnige","year":"2021","unstructured":"Sinnige, T. et al. Kinetic analysis reveals that independent nucleation events determine the progression of polyglutamine aggregation in C. elegans. Proc. Natl Acad. Sci. USA 118, e2021888118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58691_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","volume":"8","author":"W Chen","year":"2023","unstructured":"Chen, W., Zhao, H. & Li, Y. Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal Transduct. Target. Ther. 8, 1\u201325 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"58691_CR61","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41593-023-01341-4","volume":"26","author":"ST Kumar","year":"2023","unstructured":"Kumar, S. T. et al. Seeding the aggregation of TDP-43 requires post-fibrillization proteolytic cleavage. Nat. Neurosci. 26, 983\u2013996 (2023).","journal-title":"Nat. Neurosci."},{"key":"58691_CR62","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.jmb.2013.01.016","volume":"425","author":"K Kar","year":"2013","unstructured":"Kar, K. et al. \u03b2-hairpin-mediated nucleation of polyglutamine amyloid formation. J. Mol. Biol. 425, 1183\u20131197 (2013).","journal-title":"J. Mol. Biol."},{"key":"58691_CR63","first-page":"1311","volume":"24","author":"AV Kajava","year":"2010","unstructured":"Kajava, A. V., Baxa, U. & Steven, A. C. Beta arcades: recurring motifs in naturally occurring and disease-related amyloid fibrils. FASEB J. Publ. Fed. Am. Soc. Exp. Biol. 24, 1311\u20131319 (2010).","journal-title":"FASEB J. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"58691_CR64","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.bpj.2014.02.027","volume":"106","author":"MS Miettinen","year":"2014","unstructured":"Miettinen, M. S., Monticelli, L., Nedumpully-Govindan, P., Knecht, V. & Ignatova, Z. Stable polyglutamine dimers can contain \u03b2-hairpins with interdigitated side chains\u2014but not \u03b1-helices, \u03b2-nanotubes, \u03b2-pseudohelices, or steric zippers. Biophys. J. 106, 1721\u20131728 (2014).","journal-title":"Biophys. J."},{"key":"58691_CR65","doi-asserted-by":"publisher","first-page":"RP86939","DOI":"10.7554\/eLife.86939.3","volume":"12","author":"T Kandola","year":"2023","unstructured":"Kandola, T. et al. Pathologic polyglutamine aggregation begins with a self-poisoning polymer crystal. eLife 12, RP86939 (2023).","journal-title":"eLife"},{"key":"58691_CR66","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1021\/jacs.3c11155","volume":"146","author":"R Parlato","year":"2024","unstructured":"Parlato, R. et al. Photocontrol of the \u03b2-hairpin polypeptide structure through an optimized azobenzene-based amino acid analogue. J. Am. Chem. Soc. 146, 2062\u20132071 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"58691_CR67","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1021\/bi3000929","volume":"51","author":"M Jayaraman","year":"2012","unstructured":"Jayaraman, M. et al. Kinetically competing huntingtin aggregation pathways control amyloid polymorphism and properties. Biochemistry 51, 2706\u20132716 (2012).","journal-title":"Biochemistry"},{"key":"58691_CR68","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jmb.2016.12.010","volume":"429","author":"K Kar","year":"2017","unstructured":"Kar, K. et al. Backbone engineering within a latent \u03b2-hairpin structure to design inhibitors of polyglutamine amyloid formation. J. Mol. Biol. 429, 308\u2013323 (2017).","journal-title":"J. Mol. Biol."},{"key":"58691_CR69","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nsmb.1570","volume":"16","author":"AK Thakur","year":"2009","unstructured":"Thakur, A. K. et al. Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism. Nat. Struct. Mol. Biol. 16, 380\u2013389 (2009).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"58691_CR70","doi-asserted-by":"publisher","first-page":"214074","DOI":"10.1155\/2010\/214074","volume":"2010","author":"S Fulda","year":"2010","unstructured":"Fulda, S., Gorman, A. M., Hori, O. & Samali, A. Cellular stress responses: cell survival and cell death. Int. J. Cell Biol. 2010, 214074 (2010).","journal-title":"Int. J. Cell Biol."},{"key":"58691_CR71","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41380-021-01350-4","volume":"27","author":"M Alpaugh","year":"2022","unstructured":"Alpaugh, M., Denis, H. L. & Cicchetti, F. Prion-like properties of the mutant huntingtin protein in living organisms: the evidence and the relevance. Mol. Psychiatry 27, 269\u2013280 (2022).","journal-title":"Mol. Psychiatry"},{"key":"58691_CR72","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1172\/JCI80743","volume":"125","author":"EJ Wild","year":"2015","unstructured":"Wild, E. J. et al. Quantification of mutant huntingtin protein in cerebrospinal fluid from huntington\u2019s disease patients. J. Clin. Invest 125, 1979\u20131986 (2015).","journal-title":"J. Clin. Invest"},{"key":"58691_CR73","doi-asserted-by":"publisher","first-page":"29722","DOI":"10.1074\/jbc.M112.372474","volume":"287","author":"RS Trevino","year":"2012","unstructured":"Trevino, R. S. et al. Fibrillar structure and charge determine the interaction of polyglutamine protein aggregates with the cell surface. J. Biol. Chem. 287, 29722\u201329728 (2012).","journal-title":"J. Biol. Chem."},{"key":"58691_CR74","doi-asserted-by":"publisher","first-page":"9805","DOI":"10.1021\/bi700455c","volume":"46","author":"Y Yoshiike","year":"2007","unstructured":"Yoshiike, Y., Akagi, T. & Takashima, A. Surface structure of amyloid-beta fibrils contributes to cytotoxicity. Biochemistry 46, 9805\u20139812 (2007).","journal-title":"Biochemistry"},{"key":"58691_CR75","first-page":"100077","volume":"6","author":"I Matlahov","year":"2022","unstructured":"Matlahov, I., Boatz, J. C. & Van Der Wel, P. C. A. Selective observation of semi-rigid non-core residues in dynamically complex mutant huntingtin protein fibrils. J. Struct. Biol. X 6, 100077 (2022).","journal-title":"J. Struct. Biol. X"},{"key":"58691_CR76","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1093\/hmg\/ddy141","volume":"27","author":"J Ko","year":"2018","unstructured":"Ko, J. et al. Identification of distinct conformations associated with monomers and fibril assemblies of mutant huntingtin. Hum. Mol. Genet 27, 2330\u20132343 (2018).","journal-title":"Hum. Mol. Genet"},{"key":"58691_CR77","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1074\/jbc.RA117.000357","volume":"293","author":"AE Posey","year":"2018","unstructured":"Posey, A. E. et al. Profilin reduces aggregation and phase separation of huntingtin N-terminal fragments by preferentially binding to soluble monomers and oligomers. J. Biol. Chem. 293, 3734\u20133746 (2018).","journal-title":"J. Biol. Chem."},{"key":"58691_CR78","doi-asserted-by":"publisher","first-page":"611285","DOI":"10.3389\/fnins.2020.611285","volume":"14","author":"SM Ulamec","year":"2020","unstructured":"Ulamec, S. M., Brockwell, D. J. & Radford, S. E. Looking beyond the core: the role of flanking regions in the aggregation of amyloidogenic peptides and proteins. Front. Neurosci. 14, 611285 (2020).","journal-title":"Front. Neurosci."},{"key":"58691_CR79","doi-asserted-by":"publisher","first-page":"9507","DOI":"10.1021\/acs.jpcb.8b09213","volume":"122","author":"BG Caulkins","year":"2018","unstructured":"Caulkins, B. G., Cervantes, S. A., Isas, J. M. & Siemer, A. B. Dynamics of the proline-rich c-terminus of huntingtin exon\u22121 fibrils. J. Phys. Chem. B 122, 9507\u20139515 (2018).","journal-title":"J. Phys. Chem. B"},{"key":"58691_CR80","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker, F. O. Huntington\u2019s disease. Lancet 369, 218\u2013228 (2007).","journal-title":"Lancet"},{"key":"58691_CR81","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1093\/nar\/gkg563","volume":"31","author":"E Gasteiger","year":"2003","unstructured":"Gasteiger, E. et al. ExPASy: The proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res 31, 3784\u20133788 (2003).","journal-title":"Nucleic Acids Res"},{"key":"58691_CR82","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10858-017-0089-6","volume":"67","author":"A Mandal","year":"2017","unstructured":"Mandal, A., Boatz, J. C., Wheeler, T. B. & van der Wel, P. C. A. On the use of ultracentrifugal devices for routine sample preparation in biomolecular magic-angle-spinning NMR. J. Biomol. NMR 67, 165\u2013178 (2017).","journal-title":"J. Biomol. NMR"},{"key":"58691_CR83","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0009-2614(01)00791-6","volume":"344","author":"K Takegoshi","year":"2001","unstructured":"Takegoshi, K., Nakamura, S. & Terao, T. 13C\u20131H dipolar-assisted rotational resonance in magic-angle spinning NMR. Chem. Phys. Lett. 344, 631\u2013637 (2001).","journal-title":"Chem. Phys. Lett."},{"key":"58691_CR84","doi-asserted-by":"publisher","first-page":"12965","DOI":"10.1021\/ja0530164","volume":"127","author":"OC Andronesi","year":"2005","unstructured":"Andronesi, O. C. et al. Determination of membrane protein structure and dynamics by magic-angle-spinning solid-state NMR spectroscopy. J. Am. Chem. Soc. 127, 12965\u201312974 (2005).","journal-title":"J. Am. Chem. Soc."},{"key":"58691_CR85","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF00197809","volume":"6","author":"F Delaglio","year":"1995","unstructured":"Delaglio, F. et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277\u2013293 (1995).","journal-title":"J. Biomol. NMR"},{"key":"58691_CR86","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10858-013-9718-x","volume":"55","author":"JJ Helmus","year":"2013","unstructured":"Helmus, J. J. & Jaroniec, C. P. Nmrglue: an open source python package for the analysis of multidimensional NMR data. J. Biomol. NMR 55, 355\u2013367 (2013).","journal-title":"J. Biomol. NMR"},{"key":"58691_CR87","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nprot.2016.010","volume":"11","author":"G Meisl","year":"2016","unstructured":"Meisl, G. et al. Molecular mechanisms of protein aggregation from global fitting of kinetic models. Nat. Protoc. 11, 252\u2013272 (2016).","journal-title":"Nat. Protoc."},{"key":"58691_CR88","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"58691_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.530","volume":"5","author":"AM Dolga","year":"2014","unstructured":"Dolga, A. M. et al. Subcellular expression and neuroprotective effects of SK channels in human dopaminergic neurons. Cell Death Dis. 5, e999 (2014).","journal-title":"Cell Death Dis."},{"key":"58691_CR90","doi-asserted-by":"publisher","first-page":"38884","DOI":"10.1074\/jbc.M205518200","volume":"277","author":"J Lotharius","year":"2002","unstructured":"Lotharius, J. et al. Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J. Biol. Chem. 277, 38884\u201338894 (2002).","journal-title":"J. Biol. Chem."},{"key":"58691_CR91","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/cdd.2015.146","volume":"23","author":"M Richter","year":"2016","unstructured":"Richter, M. et al. Activation of SK2 channels preserves ER Ca2+ homeostasis and protects against ER stress-induced cell death. Cell Death Differ. 23, 814\u2013827 (2016).","journal-title":"Cell Death Differ."},{"key":"58691_CR92","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00204-019-02642-z","volume":"94","author":"P Kranaster","year":"2020","unstructured":"Kranaster, P. et al. Time and space-resolved quantification of plasma membrane sialylation for measurements of cell function and neurotoxicity. Arch. Toxicol. 94, 449\u2013467 (2020).","journal-title":"Arch. Toxicol."},{"key":"58691_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-230","volume":"12","author":"S-Y Ho","year":"2011","unstructured":"Ho, S.-Y. et al. NeurphologyJ: an automatic neuronal morphology quantification method and its application in pharmacological discovery. BMC Bioinforma. 12, 230 (2011).","journal-title":"BMC Bioinforma."},{"key":"58691_CR94","unstructured":"Die Abhangigkeitder Rontgen-Kleinwinkelstreuung, P. G. von form und gro\u03b2e der kolloiden teilchen in verdunnten systemen, IV. Acta Phys. Austriaca 2, 255\u2013292 (1948)."},{"key":"58691_CR95","doi-asserted-by":"publisher","unstructured":"Schweizer, K. S. & Curro, J. G. PRISM theory of the structure, thermodynamics, and phase transitions of polymer liquids and alloys. in Atomistic Modeling of Physical Properties (eds. Monnerie, L. & Suter, U. W.) 319\u2013377 (Springer, Berlin, Heidelberg, 1994). https:\/\/doi.org\/10.1007\/BFb0080203.","DOI":"10.1007\/BFb0080203"},{"key":"58691_CR96","doi-asserted-by":"publisher","first-page":"16012","DOI":"10.1039\/C8CP00355F","volume":"20","author":"J Schmitt","year":"2018","unstructured":"Schmitt, J. et al. TEMPO-oxidised cellulose nanofibrils; probing the mechanisms of gelation via small angle X-ray scattering. Phys. Chem. Chem. Phys. 20, 16012\u201316020 (2018).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"58691_CR97","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1107\/S1600576715016544","volume":"48","author":"I Bre\u00dfler","year":"2015","unstructured":"Bre\u00dfler, I., Kohlbrecher, J. & Th\u00fcnemann, A. F. SASfit: a tool for small-angle scattering data analysis using a library of analytical expressions. J. Appl. Crystallogr. 48, 1587\u20131598 (2015).","journal-title":"J. Appl. Crystallogr."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58691-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58691-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58691-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T15:03:04Z","timestamp":1744729384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58691-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58691"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-58691-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.04.24.537565","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"16 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3588"}}